These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25725773)

  • 1. Michaelis-Menten elimination kinetics of etanercept, rheumatoid arthritis biologics, after intravenous and subcutaneous administration in rats.
    Lee BY; Kwon KI; Kim MS; Baek IH
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):433-9. PubMed ID: 25725773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers.
    Gu N; Yi S; Kim TE; Kim J; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2011 Dec; 33(12):2029-37. PubMed ID: 22088414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of etanercept in healthy volunteers.
    Korth-Bradley JM; Rubin AS; Hanna RK; Simcoe DK; Lebsack ME
    Ann Pharmacother; 2000 Feb; 34(2):161-4. PubMed ID: 10676822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects.
    Shennak M; Al-Jaouni R; Kshirasagar S; Kasibhatta RS; Godse N; Al-Ghazawi A; Vittala P; Bakhle D
    Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):467-475. PubMed ID: 32172488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic delivery of etanercept via nanotopography improves response to collagen-induced arthritis.
    Aldrich MB; Velasquez FC; Kwon S; Azhdarinia A; Pinkston K; Harvey BR; Chan W; Rasmussen JC; Ross RF; Fife CE; Sevick-Muraca EM
    Arthritis Res Ther; 2017 May; 19(1):116. PubMed ID: 28566090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritis.
    Lon HK; Liu D; Zhang Q; DuBois DC; Almon RR; Jusko WJ
    Pharm Res; 2011 Jul; 28(7):1622-30. PubMed ID: 21360252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis.
    Rho YH; Rychlewska-Hańczewska A; Śliwowska B; Kim TH
    Adv Ther; 2019 Sep; 36(9):2287-2295. PubMed ID: 31372961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study.
    Girolomoni G; Feldman SR; Emery P; Ghil J; Keum JW; Cheong SY; Hong E
    Br J Dermatol; 2018 Mar; 178(3):e215-e216. PubMed ID: 29023641
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects.
    Lee YJ; Shin D; Kim Y; Kang J; Gauliard A; Fuhr R
    Br J Clin Pharmacol; 2016 Jul; 82(1):64-73. PubMed ID: 26972584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H
    J Clin Pharmacol; 2005 May; 45(5):490-7. PubMed ID: 15831771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.
    Abdallah H; Hsu JC; Lu P; Fettner S; Zhang X; Douglass W; Bao M; Rowell L; Burmester GR; Kivitz A
    J Clin Pharmacol; 2017 Apr; 57(4):459-468. PubMed ID: 27599663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept biosimilar SB-4.
    Pelechas E; Drosos AA
    Expert Opin Biol Ther; 2019 Mar; 19(3):173-179. PubMed ID: 30616405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes.
    von Richter O; Skerjanec A; Afonso M; Sanguino Heinrich S; Poetzl J; Woehling H; Velinova M; Koch A; Kollins D; Macke L; Wuerth G
    Br J Clin Pharmacol; 2017 Apr; 83(4):732-741. PubMed ID: 27790726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male Subjects.
    Lee H; Chung H; Lee S; Lee H; Yang SM; Yoon SH; Cho JY; Jang IJ; Yu KS
    BioDrugs; 2017 Aug; 31(4):349-355. PubMed ID: 28551775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurement.
    Bouman C; van Herwaarden N; van den Hoogen F; van der Maas A; van den Bemt B; den Broeder AA
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):597-604. PubMed ID: 28425772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GP2015 as a promising therapy for rheumatoid arthritis.
    Fitton J; Giollo A; Buch MH
    Expert Opin Biol Ther; 2018 Apr; 18(4):477-481. PubMed ID: 29558865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats.
    Gao X; Voronin G; Generaux C; Rose A; Kozhich A; Dalglish G; Rosa R; Oh S; Kagan L
    Pharm Res; 2020 Jul; 37(8):155. PubMed ID: 32720159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey.
    Aladul MI; Fitzpatrick RW; Chapman SR
    BioDrugs; 2017 Oct; 31(5):439-446. PubMed ID: 28752242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study.
    Zhuang Y; Xu Z; Frederick B; de Vries DE; Ford JA; Keen M; Doyle MK; Petty KJ; Davis HM; Zhou H
    Clin Ther; 2012 Jan; 34(1):77-90. PubMed ID: 22169051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.